Drug and vaccine authorizations for COVID-19: Overview
When a company decides it would like to sell a drug or vaccine in Canada, it files a submission with Health Canada. A new drug submission contains detailed scientific information about the drug's safety, efficacy and quality. Health Canada scientific reviewers evaluate data to assess the potential benefits and risks of a drug or vaccine. They also review the information that will be provided to health care practitioners and consumers about the product. After the review, we may authorize the drug or vaccine for sale in Canada only if the benefits of the product outweigh the potential risks.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-08-26
Data overview
- Formats
- HTML
- File languages
- English, French